37 results
424B5
ELVN
Enliven Therapeutics Inc
6 Jul 23
Prospectus supplement for primary offering
4:06pm
party to acquire, or discourage a third party from seeking to acquire, control of our company.
Stockholder Action; Special Meeting of Stockholders … bylaws provide that any action required or permitted to be taken by our stockholders at an annual meeting or special meeting of stockholders may only
S-4/A
q9hzd9e
19 Dec 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
0uxk 3l4lhoye7l
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
8-K
onrjogjmwuf
10 Nov 22
Completion of Acquisition or Disposition of Assets
4:17pm
DEFA14A
yxwk054
19 Oct 22
Additional proxy soliciting materials
4:05pm
425
pkobspetwyrgtvpo9
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-2.1
d2lr1tv80ox161
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
DEFM14A
rz7qq0ipqih8dlhi
7 Oct 22
Proxy related to merger
5:10pm
PREM14A
db0108vo481yzsd
23 Sep 22
Preliminary proxy related to merger
5:04pm
424B5
x8s 91jsqo
14 Jul 21
Prospectus supplement for primary offering
4:16pm
424B5
kkbtal gbhom716ajl
13 Jul 21
Prospectus supplement for primary offering
4:20pm
S-3
wooz 3m4a4idl48c0o53
1 Apr 21
Shelf registration
5:18pm
10-K
EX-4.3
0chg8by7
5 Mar 21
Annual report
7:26am
8-K
EX-3.1
oxq9v k2en0d6
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
EX-3.2
rt1gr47t
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
424B4
q0g40bxqeyde
12 Mar 20
Prospectus supplement with pricing info
4:03pm